| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 2.13e-04 | 5 | 93 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 2.64e-04 | 27 | 93 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 2.94e-04 | 28 | 93 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 4.00e-04 | 31 | 93 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 4.40e-04 | 32 | 93 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 7.56e-04 | 9 | 93 | 2 | GO:0010854 | |
| GeneOntologyMolecularFunction | protein-glutamic acid ligase activity | 9.42e-04 | 10 | 93 | 2 | GO:0070739 | |
| GeneOntologyMolecularFunction | tubulin-glutamic acid ligase activity | 9.42e-04 | 10 | 93 | 2 | GO:0070740 | |
| GeneOntologyMolecularFunction | demethylase activity | 1.13e-03 | 44 | 93 | 3 | GO:0032451 | |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 1.15e-03 | 11 | 93 | 2 | GO:0051864 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.15e-03 | 11 | 93 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.54e-03 | 363 | 93 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.62e-03 | 182 | 93 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.70e-03 | 184 | 93 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAP7D3 PICALM MAP3K1 TTLL7 MYO3A PTPRN ARHGEF10 TTLL2 FARP1 SIPA1L1 KIF19 STK38L ALDOB | 1.71e-03 | 1099 | 93 | 13 | GO:0008092 |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 1.88e-03 | 14 | 93 | 2 | GO:0032454 | |
| HumanPheno | Abnormality of the female genitalia | RAF1 HSPG2 ROR2 DDB1 JMJD1C MAP3K1 ORC4 FREM2 NPHP3 PNPLA6 GLI2 PTCH2 FIGLA | 5.30e-05 | 741 | 28 | 13 | HP:0010460 |
| HumanPheno | Abnormal testis morphology | THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1 | 6.01e-05 | 1129 | 28 | 16 | HP:0000035 |
| HumanPheno | Non-obstructive azoospermia | THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1 | 6.22e-05 | 1132 | 28 | 16 | HP:0011961 |
| HumanPheno | Azoospermia | THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1 | 8.26e-05 | 1157 | 28 | 16 | HP:0000027 |
| HumanPheno | Cryptorchidism | RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1 | 9.19e-05 | 780 | 28 | 13 | HP:0000028 |
| HumanPheno | Abnormal male external genitalia morphology | THSD4 RAF1 HSPG2 ROR2 PHF8 GRM7 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1 | 1.12e-04 | 1329 | 28 | 17 | HP:0000032 |
| HumanPheno | Abnormal spermatogenesis | THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1 | 1.18e-04 | 1190 | 28 | 16 | HP:0008669 |
| HumanPheno | Abnormal internal genitalia | THSD4 RAF1 HSPG2 ROR2 PHF8 DDB1 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 FIGLA CPLANE1 | 1.32e-04 | 1498 | 28 | 18 | HP:0000812 |
| HumanPheno | Abnormal external genitalia | THSD4 RAF1 HSPG2 ROR2 PHF8 GRM7 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1 | 1.72e-04 | 1372 | 28 | 17 | HP:0000811 |
| HumanPheno | Abnormal male internal genitalia morphology | THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1 | 2.06e-04 | 1243 | 28 | 16 | HP:0000022 |
| HumanPheno | Epicanthus | RAF1 HSPG2 ROR2 DDB1 JMJD1C PNPLA6 CLCN3 CLCN7 GLI2 PTCH2 CPLANE1 | 2.21e-04 | 614 | 28 | 11 | HP:0000286 |
| Domain | DUF1712 | 2.40e-05 | 2 | 92 | 2 | PF08217 | |
| Domain | DUF1712_fun | 2.40e-05 | 2 | 92 | 2 | IPR013176 | |
| Domain | JmjC | 2.17e-04 | 24 | 92 | 3 | PF02373 | |
| Domain | RBD | 3.55e-04 | 6 | 92 | 2 | PF02196 | |
| Domain | RBD | 4.96e-04 | 7 | 92 | 2 | SM00455 | |
| Domain | RBD_dom | 4.96e-04 | 7 | 92 | 2 | IPR003116 | |
| Domain | RBD | 4.96e-04 | 7 | 92 | 2 | PS50898 | |
| Domain | JMJC | 5.17e-04 | 32 | 92 | 3 | PS51184 | |
| Domain | JmjC_dom | 5.17e-04 | 32 | 92 | 3 | IPR003347 | |
| Domain | JmjC | 5.67e-04 | 33 | 92 | 3 | SM00558 | |
| Domain | Cl-channel_core | 8.45e-04 | 9 | 92 | 2 | IPR014743 | |
| Domain | - | 8.45e-04 | 9 | 92 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 8.45e-04 | 9 | 92 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 8.45e-04 | 9 | 92 | 2 | IPR001807 | |
| Domain | Rap_GAP | 1.05e-03 | 10 | 92 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 1.28e-03 | 11 | 92 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.28e-03 | 11 | 92 | 2 | PS50085 | |
| Domain | Laminin_G_1 | 1.28e-03 | 11 | 92 | 2 | PF00054 | |
| Domain | TTL | 1.81e-03 | 13 | 92 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 1.81e-03 | 13 | 92 | 2 | IPR004344 | |
| Domain | TTL | 1.81e-03 | 13 | 92 | 2 | PF03133 | |
| Domain | SEA | 2.10e-03 | 14 | 92 | 2 | SM00200 | |
| Domain | Ig_I-set | 2.49e-03 | 190 | 92 | 5 | IPR013098 | |
| Domain | I-set | 2.49e-03 | 190 | 92 | 5 | PF07679 | |
| Domain | CBS | 2.75e-03 | 16 | 92 | 2 | SM00116 | |
| Domain | CBS_dom | 4.30e-03 | 20 | 92 | 2 | IPR000644 | |
| Domain | CBS | 4.30e-03 | 20 | 92 | 2 | PF00571 | |
| Domain | CBS | 4.30e-03 | 20 | 92 | 2 | PS51371 | |
| Domain | DAG/PE-bd | 4.74e-03 | 21 | 92 | 2 | IPR020454 | |
| Domain | SEA | 5.20e-03 | 22 | 92 | 2 | PF01390 | |
| Domain | Kinase-like_dom | 5.27e-03 | 542 | 92 | 8 | IPR011009 | |
| Domain | SEA | 5.68e-03 | 23 | 92 | 2 | PS50024 | |
| Domain | SEA_dom | 5.68e-03 | 23 | 92 | 2 | IPR000082 | |
| Domain | IGc2 | 6.12e-03 | 235 | 92 | 5 | SM00408 | |
| Domain | Ig_sub2 | 6.12e-03 | 235 | 92 | 5 | IPR003598 | |
| Pathway | WP_MAPK_CASCADE | 3.09e-04 | 28 | 67 | 3 | MM15976 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 3.38e-04 | 70 | 67 | 4 | MM14984 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 4.60e-04 | 7 | 67 | 2 | M27501 | |
| Pathway | WP_MAPK_CASCADE | 5.06e-04 | 33 | 67 | 3 | M39594 | |
| Pathway | REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS | 6.12e-04 | 8 | 67 | 2 | M38999 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE | 6.12e-04 | 8 | 67 | 2 | M47933 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 6.55e-04 | 36 | 67 | 3 | M39908 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 7.47e-04 | 151 | 67 | 5 | M39801 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY | 9.77e-04 | 10 | 67 | 2 | M47374 | |
| Pathway | KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY | 9.77e-04 | 10 | 67 | 2 | M47420 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY | 9.77e-04 | 10 | 67 | 2 | M47735 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.19e-03 | 11 | 67 | 2 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.19e-03 | 11 | 67 | 2 | M47371 | |
| Pathway | WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ | 1.42e-03 | 12 | 67 | 2 | M39552 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.42e-03 | 12 | 67 | 2 | M47369 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY | 1.42e-03 | 12 | 67 | 2 | M47597 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 1.42e-03 | 12 | 67 | 2 | M47815 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 1.68e-03 | 13 | 67 | 2 | M47589 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M47383 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M47384 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M47414 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M47488 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47382 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 2.56e-03 | 16 | 67 | 2 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.56e-03 | 16 | 67 | 2 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 2.56e-03 | 16 | 67 | 2 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 2.56e-03 | 16 | 67 | 2 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 2.56e-03 | 16 | 67 | 2 | M47801 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.56e-03 | 16 | 67 | 2 | M27410 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 2.56e-03 | 16 | 67 | 2 | M39675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 2.56e-03 | 16 | 67 | 2 | M47483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 2.56e-03 | 16 | 67 | 2 | M47682 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 2.89e-03 | 17 | 67 | 2 | M47376 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.89e-03 | 17 | 67 | 2 | M27412 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 2.89e-03 | 17 | 67 | 2 | M47684 | |
| Pubmed | Mammalian Ras interacts directly with the serine/threonine kinase Raf. | 7.70e-06 | 2 | 97 | 2 | 8334704 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27240957 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 18317225 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23544943 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15856007 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22110214 | ||
| Pubmed | RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. | 2.31e-05 | 3 | 97 | 2 | 20130576 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23053434 | ||
| Pubmed | Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. | 2.31e-05 | 3 | 97 | 2 | 15706348 | |
| Pubmed | Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. | 2.31e-05 | 3 | 97 | 2 | 14688025 | |
| Pubmed | Expression of raf family proto-oncogenes in normal mouse tissues. | 2.31e-05 | 3 | 97 | 2 | 1690378 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 32160108 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20052757 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 9207797 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 30236127 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 2.31e-05 | 3 | 97 | 2 | 17592322 | |
| Pubmed | Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling. | 2.31e-05 | 3 | 97 | 2 | 23352452 | |
| Pubmed | Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. | 2.31e-05 | 3 | 97 | 2 | 10704835 | |
| Pubmed | ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers. | 2.31e-05 | 3 | 97 | 2 | 22926515 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 35879412 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 27483328 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 24204560 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 24939955 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18235088 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 3.57e-05 | 219 | 97 | 6 | 31353912 | |
| Pubmed | 3.58e-05 | 23 | 97 | 3 | 31226309 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 8394352 | ||
| Pubmed | Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. | 4.60e-05 | 4 | 97 | 2 | 17397260 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 11909642 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 8621729 | ||
| Pubmed | Aberrant expression of COT is related to recurrence of papillary thyroid cancer. | 4.60e-05 | 4 | 97 | 2 | 25674762 | |
| Pubmed | Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. | 4.60e-05 | 4 | 97 | 2 | 17110406 | |
| Pubmed | B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222. | 4.60e-05 | 4 | 97 | 2 | 7731720 | |
| Pubmed | Functional characterization of a PROTAC directed against BRAF mutant V600E. | 4.60e-05 | 4 | 97 | 2 | 32778845 | |
| Pubmed | A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. | 4.60e-05 | 4 | 97 | 2 | 8385802 | |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 4.60e-05 | 4 | 97 | 2 | 39024979 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 20305638 | ||
| Pubmed | Human adolescent nephronophthisis: gene locus synteny with polycystic kidney disease in pcy mice. | 7.66e-05 | 5 | 97 | 2 | 11134256 | |
| Pubmed | Germline gain-of-function mutations in RAF1 cause Noonan syndrome. | 7.66e-05 | 5 | 97 | 2 | 17603482 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 17219248 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 24746704 | ||
| Pubmed | Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors. | 8.08e-05 | 30 | 97 | 3 | 34017080 | |
| Pubmed | Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. | 1.15e-04 | 6 | 97 | 2 | 8157000 | |
| Pubmed | Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. | 1.15e-04 | 6 | 97 | 2 | 19487286 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 10848612 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 34251884 | ||
| Pubmed | Wound-healing plasticity enables clonal expansion of founder progenitor cells in colitis. | 1.15e-04 | 6 | 97 | 2 | 37652012 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.37e-04 | 853 | 97 | 10 | 28718761 | |
| Pubmed | 1.40e-04 | 36 | 97 | 3 | 35379950 | ||
| Pubmed | CCDC80 DNAAF9 WDR76 PICALM CRHR2 FREM2 CCZ1 ARHGEF10 FER1L4 RIPOR1 MMS19 HOMER3 | 1.45e-04 | 1215 | 97 | 12 | 15146197 | |
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 9488663 | ||
| Pubmed | An ARL3-UNC119-RP2 GTPase cycle targets myristoylated NPHP3 to the primary cilium. | 1.60e-04 | 7 | 97 | 2 | 22085962 | |
| Pubmed | Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation. | 1.60e-04 | 7 | 97 | 2 | 21336309 | |
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 1.65e-04 | 38 | 97 | 3 | 19608861 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 9808624 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 22869526 | ||
| Pubmed | Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. | 2.13e-04 | 8 | 97 | 2 | 10529434 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 10969079 | ||
| Pubmed | Expression of hedgehog signalling components in adult mouse testis. | 2.13e-04 | 8 | 97 | 2 | 16958114 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 2.13e-04 | 8 | 97 | 2 | 33875569 | |
| Pubmed | Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. | 2.13e-04 | 8 | 97 | 2 | 10027293 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 27235625 | ||
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 19667065 | ||
| Pubmed | AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness. | 2.74e-04 | 9 | 97 | 2 | 30595535 | |
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 17967876 | ||
| Pubmed | Phosphorylation-dependent interaction of kinesin light chain 2 and the 14-3-3 protein. | 2.74e-04 | 9 | 97 | 2 | 11969417 | |
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 2.74e-04 | 9 | 97 | 2 | 23115349 | |
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 10523642 | ||
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 18832395 | ||
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 15866172 | ||
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 18816447 | ||
| Pubmed | Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. | 3.12e-04 | 47 | 97 | 3 | 32747435 | |
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 10512189 | ||
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 15192046 | ||
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 17889508 | ||
| Pubmed | Essential role of B-Raf in ERK activation during extraembryonic development. | 3.41e-04 | 10 | 97 | 2 | 16432225 | |
| Pubmed | Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling. | 3.41e-04 | 10 | 97 | 2 | 28344083 | |
| Pubmed | 3.41e-04 | 10 | 97 | 2 | 22609986 | ||
| Pubmed | 3.53e-04 | 49 | 97 | 3 | 34368113 | ||
| Pubmed | 3.65e-04 | 120 | 97 | 4 | 31298480 | ||
| Pubmed | 4.17e-04 | 11 | 97 | 2 | 9671585 | ||
| Pubmed | 4.17e-04 | 11 | 97 | 2 | 15668330 | ||
| Pubmed | Congenital Hepatic Fibrosis Overview ─ RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 4.21e-04 | 52 | 97 | 3 | 20301743 | |
| Pubmed | 4.99e-04 | 12 | 97 | 2 | 11389830 | ||
| Pubmed | 4.99e-04 | 12 | 97 | 2 | 36459481 | ||
| Pubmed | 4.99e-04 | 12 | 97 | 2 | 19445942 | ||
| Pubmed | Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. | 4.99e-04 | 12 | 97 | 2 | 10981962 | |
| Pubmed | Vsx2/Chx10 ensures the correct timing and magnitude of Hedgehog signaling in the mouse retina. | 4.99e-04 | 12 | 97 | 2 | 18417110 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.52e-04 | 363 | 97 | 6 | 14691545 | |
| Pubmed | Expression patterns of Hedgehog signalling pathway members during mouse palate development. | 5.89e-04 | 13 | 97 | 2 | 16168717 | |
| Pubmed | A targeted multienzyme mechanism for selective microtubule polyglutamylation. | 5.89e-04 | 13 | 97 | 2 | 17499049 | |
| Pubmed | Residual embryonic cells as precursors of a Barrett's-like metaplasia. | 5.89e-04 | 13 | 97 | 2 | 21703447 | |
| Pubmed | Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development. | 5.89e-04 | 13 | 97 | 2 | 25448692 | |
| Pubmed | 5.89e-04 | 13 | 97 | 2 | 25352737 | ||
| Pubmed | 5.89e-04 | 13 | 97 | 2 | 32332736 | ||
| Pubmed | TFEB regulates murine liver cell fate during development and regeneration. | 5.89e-04 | 13 | 97 | 2 | 32424153 | |
| Pubmed | Gli2 influences proliferation in the developing lung through regulation of cyclin expression. | 5.89e-04 | 13 | 97 | 2 | 19574535 | |
| Pubmed | 5.89e-04 | 13 | 97 | 2 | 22863007 | ||
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 5.89e-04 | 13 | 97 | 2 | 36335435 | |
| Pubmed | 5.99e-04 | 242 | 97 | 5 | 34011540 | ||
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 7.38e-05 | 24 | 62 | 3 | 654 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 7.38e-05 | 24 | 62 | 3 | 485 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.15e-04 | 5 | 62 | 2 | 1157 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.26e-04 | 161 | 62 | 5 | 593 | |
| GeneFamily | Chloride voltage-gated channels | 5.12e-04 | 10 | 62 | 2 | 302 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.03e-03 | 14 | 62 | 2 | 779 | |
| GeneFamily | Olfactory receptors, family 10 | 1.51e-03 | 66 | 62 | 3 | 157 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 1.71e-03 | 18 | 62 | 2 | 1269 | |
| GeneFamily | CD molecules|Mucins | 2.33e-03 | 21 | 62 | 2 | 648 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 9.82e-06 | 33 | 87 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_200 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.46e-07 | 198 | 96 | 7 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-06 | 167 | 96 | 6 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-06 | 167 | 96 | 6 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 171 | 96 | 6 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 171 | 96 | 6 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-06 | 176 | 96 | 6 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.43e-06 | 178 | 96 | 6 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 3.04e-06 | 185 | 96 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-06 | 188 | 96 | 6 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 189 | 96 | 6 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 189 | 96 | 6 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 191 | 96 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 3.76e-06 | 192 | 96 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.76e-06 | 192 | 96 | 6 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 192 | 96 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-06 | 193 | 96 | 6 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.88e-06 | 193 | 96 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 193 | 96 | 6 | 1526f51b589a7dc7a28f35f0e788dc38d338d2bc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.99e-06 | 194 | 96 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.11e-06 | 195 | 96 | 6 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 195 | 96 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.24e-06 | 196 | 96 | 6 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.24e-06 | 196 | 96 | 6 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-06 | 197 | 96 | 6 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.36e-06 | 197 | 96 | 6 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | Nasal_Brush-Epithelial|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.76e-06 | 200 | 96 | 6 | 7911073119ee47a37b68b73fc54f063e902a5067 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.76e-06 | 200 | 96 | 6 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.23e-06 | 130 | 96 | 5 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 134 | 96 | 5 | 72d7eec3aeb43319f3ef81bb5518fae8d8880136 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.23e-05 | 138 | 96 | 5 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.60e-05 | 70 | 96 | 4 | 2121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.60e-05 | 70 | 96 | 4 | cd6bca68fe52f451716fc8c0b1745984bc9ec057 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.60e-05 | 70 | 96 | 4 | be300c0447735aba89df4c3082b81eb5abf22770 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 175 | 96 | 5 | 9a96794df049d8228fea57c1584c160191d36b56 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 176 | 96 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 176 | 96 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-05 | 178 | 96 | 5 | f332c7a96844abecf05ca057480fbea9296688a2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-05 | 178 | 96 | 5 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-05 | 178 | 96 | 5 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-05 | 178 | 96 | 5 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.19e-05 | 178 | 96 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 179 | 96 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 180 | 96 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-05 | 180 | 96 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.41e-05 | 180 | 96 | 5 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 182 | 96 | 5 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 182 | 96 | 5 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-05 | 183 | 96 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.90e-05 | 184 | 96 | 5 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.90e-05 | 184 | 96 | 5 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.03e-05 | 185 | 96 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.03e-05 | 185 | 96 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.03e-05 | 185 | 96 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.03e-05 | 185 | 96 | 5 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 186 | 96 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.16e-05 | 186 | 96 | 5 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 186 | 96 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 186 | 96 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 187 | 96 | 5 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 5.29e-05 | 187 | 96 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 5.43e-05 | 188 | 96 | 5 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 189 | 96 | 5 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 5.56e-05 | 189 | 96 | 5 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 5.56e-05 | 189 | 96 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.70e-05 | 190 | 96 | 5 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 190 | 96 | 5 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-05 | 190 | 96 | 5 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.70e-05 | 190 | 96 | 5 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-05 | 190 | 96 | 5 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-05 | 190 | 96 | 5 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.85e-05 | 191 | 96 | 5 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.85e-05 | 191 | 96 | 5 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 191 | 96 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-05 | 191 | 96 | 5 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.85e-05 | 191 | 96 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-05 | 191 | 96 | 5 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | background-Cholangiocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.85e-05 | 191 | 96 | 5 | 99aa8d685767a72bef9f05e7cc8913126a048c39 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 191 | 96 | 5 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 191 | 96 | 5 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 191 | 96 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-05 | 191 | 96 | 5 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-05 | 192 | 96 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 192 | 96 | 5 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.99e-05 | 192 | 96 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 192 | 96 | 5 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-05 | 192 | 96 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-05 | 193 | 96 | 5 | 463274f394757fb2570ae885d58e1f9fa7e60c4a | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 6.14e-05 | 193 | 96 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 193 | 96 | 5 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 193 | 96 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 193 | 96 | 5 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 193 | 96 | 5 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 193 | 96 | 5 | 22ebc3f586eb0aabc5785e468c88d7416c624ff4 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 194 | 96 | 5 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 194 | 96 | 5 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 194 | 96 | 5 | 0ef63abcfd057079a9a6f8b27404ff521d44845d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 194 | 96 | 5 | 550e61a40be2baa59520aaf5912bb99ad094ba15 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 194 | 96 | 5 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 194 | 96 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| Disease | Polydactyly | 2.86e-05 | 117 | 89 | 5 | C0152427 | |
| Disease | Polyneuropathy | 5.38e-05 | 4 | 89 | 2 | C0152025 | |
| Disease | bipolar disorder, cytomegalovirus seropositivity | 5.38e-05 | 4 | 89 | 2 | EFO_0007037, MONDO_0004985 | |
| Disease | Basal Cell Nevus Syndrome | 8.94e-05 | 5 | 89 | 2 | C0004779 | |
| Disease | cortical thickness | THSD4 HSPG2 DNAAF9 RFX4 JMJD1C MAP3K1 KCTD3 PKHD1 KCNS3 TMEM108 FIGLA ULK2 | 1.28e-04 | 1113 | 89 | 12 | EFO_0004840 |
| Disease | osteopetrosis (implicated_via_orthology) | 1.87e-04 | 7 | 89 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | Drug-induced agranulocytosis, response to clozapine | 2.80e-04 | 42 | 89 | 3 | GO_0097338, HP_0012235 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 3.19e-04 | 9 | 89 | 2 | C0085548 | |
| Disease | cystic fibrosis, lung disease severity measurement | 3.19e-04 | 9 | 89 | 2 | EFO_0007744, MONDO_0009061 | |
| Disease | colorectal cancer | 4.85e-04 | 604 | 89 | 8 | MONDO_0005575 | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 8.00e-04 | 14 | 89 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | diffuse idiopathic skeletal hyperostosis | 9.21e-04 | 15 | 89 | 2 | EFO_0007236 | |
| Disease | cholangiocarcinoma (is_marker_for) | 9.68e-04 | 64 | 89 | 3 | DOID:4947 (is_marker_for) | |
| Disease | cognitive function measurement | NMNAT2 SZT2 GRM7 GLCCI1 JMJD1C TTLL7 ARMS2 MYO3A ARHGEF10 TTLL2 FARP1 PKHD1 | 1.23e-03 | 1434 | 89 | 12 | EFO_0008354 |
| Disease | response to alcohol | 1.53e-03 | 75 | 89 | 3 | EFO_0005526 | |
| Disease | late-onset Alzheimers disease | 1.93e-03 | 292 | 89 | 5 | EFO_1001870 | |
| Disease | Ovarian Serous Adenocarcinoma | 2.18e-03 | 23 | 89 | 2 | C1335177 | |
| Disease | triacylglycerol 52:6 measurement | 2.58e-03 | 25 | 89 | 2 | EFO_0010418 | |
| Disease | response to methotrexate, drug-induced liver injury | 2.79e-03 | 26 | 89 | 2 | EFO_0004228, GO_0031427 | |
| Disease | facial morphology measurement | 2.90e-03 | 466 | 89 | 6 | EFO_0007841 | |
| Disease | Parkinson disease | 2.91e-03 | 321 | 89 | 5 | MONDO_0005180 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MASLSSSVVPVSFIS | 21 | P0C7Q2 | |
| ATVSSRPSHDSRVMS | 676 | O15013 | |
| APHVMTSSTVEVSKS | 2026 | Q8IZF6 | |
| FSRKTMSPSTTDHTL | 2126 | Q8IZF6 | |
| MSPLFTSTFTLNISH | 886 | Q86TB3 | |
| MATVTALHRTVPAAV | 251 | P05062 | |
| TISHTQATGSRSVPM | 266 | Q86VQ1 | |
| TVATSTHRTTVPSTM | 656 | A6H8M9 | |
| TFLPETRIMTSVTFT | 251 | O95905 | |
| TTAFPHVAATLSIMD | 581 | Q9ULK2 | |
| SRAVTVAARPMTTTA | 366 | Q76M96 | |
| RSTSTPNVHMVSTTL | 256 | P04049 | |
| SFSLSSTEVHMVRPG | 126 | Q9H714 | |
| SMPIRIESSSSHVAE | 2726 | P98160 | |
| TRVIRDMTLHSAPSF | 436 | Q33E94 | |
| ALNRVTASHPFMTAV | 286 | O43929 | |
| RFPHSEETTTMSRST | 5896 | Q8WXI7 | |
| TVTQRFSHSEMTTLV | 8231 | Q8WXI7 | |
| FPESRFTMSVTESTH | 10246 | Q8WXI7 | |
| ISTIPSTAMHTRSTA | 4291 | Q99102 | |
| SVVLSAAHTVAARMS | 621 | Q8IY17 | |
| MTLVSPSGRTISFHS | 81 | Q8NGN6 | |
| QTAHSTSPMRSVLLT | 566 | Q16849 | |
| MTLVSPSGRAISFHS | 81 | Q8NGN3 | |
| TSVSHMPIRTSAATL | 1366 | Q5T1H1 | |
| FTKTPHDITIRTTTM | 601 | Q96JA1 | |
| MSTVIHIRSETSVPD | 41 | Q01629 | |
| MSIHFSSPVFTSRSA | 1 | P08729 | |
| AMVSVIGTATTHLSP | 656 | Q96T76 | |
| CSVPHRTTDVAMLVT | 196 | Q9BY71 | |
| PTHLTVSSTNTLRSM | 1186 | Q15652 | |
| VLSHPASFTSSVIMS | 2756 | Q5SZK8 | |
| ITAFHSQTLPFMATR | 91 | A9Z1Z3 | |
| LSITTELTHPSNMRF | 896 | Q5JUK3 | |
| TVGSTSPMTSRHRVT | 1016 | Q86SJ6 | |
| MSTAREQPIFSTRAH | 1 | Q9NSC5 | |
| TSHSLTAREVMSTPV | 621 | P51798 | |
| CVSVTVPAMLSHFIS | 76 | P47883 | |
| MVTVTCRSTLHSPLY | 46 | Q8NH43 | |
| PSMVHSSLTPFSVQV | 371 | Q16649 | |
| MSIPTSPTRISFHSI | 391 | Q13324 | |
| RSVHSSPTLSMISAA | 131 | P10070 | |
| QRMHTFITSLSSVGI | 446 | Q9BQ31 | |
| ATSTVEVIFHVSTRM | 1711 | Q2PPJ7 | |
| PHSVSVATAQMARIT | 26 | A0A075B6K2 | |
| MSSITFPAVSALVSR | 346 | Q96MC6 | |
| RTVMIAHISPASSAF | 316 | Q2TAC6 | |
| RSTSTPNVHMVSTTA | 211 | P10398 | |
| KVSPFHFTTLSTSVM | 1246 | Q6WRI0 | |
| SLNLSPVMSRSHSVV | 821 | Q96AV8 | |
| TTLRFLDSLSPSVHM | 421 | Q9H799 | |
| MEVIRSATSSASRPH | 1021 | Q9Y4F1 | |
| FCRAQISMTTTSHLP | 166 | Q9NZC4 | |
| PLVTRHNSAATAMVT | 666 | O15063 | |
| TVHMRKTPSVSLTSV | 391 | P86791 | |
| TVHMRKTPSVSLTSV | 391 | P86790 | |
| HFAISSISQEPVMRT | 711 | Q5TEA3 | |
| VVSRPSSKRMTSHTT | 826 | Q8IWC1 | |
| VVTAATMSSRLSHKP | 866 | Q14831 | |
| SRIPSFTQLHSTMTR | 6 | Q6UXQ4 | |
| CRHSVMSTTEIISPT | 186 | Q6QHK4 | |
| TFTVHRSPVTKIMLS | 416 | Q9Y597 | |
| IIPRSILMTTFESSH | 586 | Q16531 | |
| MTHSLVCPETVSRVS | 1 | Q86WQ0 | |
| MTLVSPSGRAISFHS | 81 | Q8NGN4 | |
| ITVIIMYIRPSSSHS | 251 | Q8NGF7 | |
| LSSARMVTTVPHVFS | 821 | Q13233 | |
| VSRSSAHMVSRFLLP | 2541 | Q5T011 | |
| SHRSTSQILPSMSVS | 821 | O14607 | |
| EIASMRHVTTSTLLT | 721 | A5PLK6 | |
| RSRTPMTFTTHIEDV | 836 | Q7Z5M5 | |
| GTTTTFPMSNHTRER | 6 | Q9Y2H1 | |
| ILSHFVGRPMSTSSE | 556 | Q7Z494 | |
| TSIRRHSVSEMTSCP | 276 | P85299 | |
| QSFARVTTSMTVAIH | 1151 | Q9Y6C5 | |
| SMSSSSRIVTHDIPI | 121 | O60921 | |
| FLRSVSMPAETAHIS | 46 | Q96CC6 | |
| MSSRHSASPVVFTSA | 1426 | O43166 | |
| RMTAVPVALSLTASF | 51 | Q8N695 | |
| TPVSALLHSSTMVVA | 241 | P03915 | |
| RSGVSIHLALTVMVS | 3556 | P08F94 | |
| ITAAFTMIGTSTHLS | 206 | Q01974 | |
| LRSILDMSPFTVTDH | 751 | P51790 | |
| STFTTRTPTHEMFVG | 456 | Q13492 | |
| MSFLRITPSTHSSVS | 1 | Q8N7C7 | |
| QLPTCFMSTHRIVTE | 106 | Q5TEJ8 | |
| HVMERSLSPSLSSVD | 186 | O95073 | |
| RTSSFRMTEHNSVKP | 126 | Q9BWV7 | |
| APTCTHMFLRTRTTS | 736 | Q8IYT8 | |
| HMFLRTRTTSVGPSN | 741 | Q8IYT8 | |
| MAPVKISHVVSFSSQ | 1 | Q6ZNB5 | |
| IFSMALHPSETRTLV | 316 | Q9H967 | |
| RPAHSTSVSMSRLSL | 506 | Q9UPP1 | |
| STEVHVRAIKTMTSF | 226 | Q9NYW2 | |
| TRSVVCMTNHVSSLP | 816 | Q6ZMP0 | |
| SHQAVIMSTSLRVSP | 6 | Q9NR00 | |
| LSRVSRMFSVAHPAA | 56 | Q6ZS17 | |
| MISVSRPTSASRSHS | 626 | Q6ZT98 | |
| GHATPVSSLMFTTIR | 206 | Q15061 | |
| VTAPHSSTRHTSVVM | 51 | Q6UXF1 | |
| MSSFKHQRIVTTPTE | 1371 | Q8NEV4 | |
| INHPMSVVSSTKSRL | 261 | Q9BZQ4 |